

Korro Bio stock rises after earnings as analysts upgrade outlook, highlight new drug candidate, and long-term growth plans.
You can purchase shares of Korro Bio (NASDAQ:KRRO) through any online brokerage.
Other companies in Korro Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Korro Bio has a consensus price target of $36.50.
The stock price for Korro Bio (NASDAQ: KRRO) is $14.73 last updated November 5, 2026 at 4:26 PM EST.
There are no upcoming dividends for Korro Bio.
Korro Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Korro Bio.
Korro Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio...